Joseph Pidala

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko et al. · Biology of Blood and Marrow Transplantation · 2015 · 419 citations · Full text

Life Sciences, Immunology, Immunotherapy +12

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Joseph Pidala, Brenda F. Kurland, Xiaoyu Chai et al. · Blood · 2011 · 388 citations · Full text

Life Sciences, Internal Medicine, Transplant Immunology +14

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

John Koreth, Joseph Pidala, Waleska S. Pérez et al. · Journal of Clinical Oncology · 2013 · 284 citations · Full text

Medicine, Geriatric Medicine, Hematology +17

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 281 citations

Medicine, Immunology, Pharmacotherapy +16

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Joseph Pidala, Stephanie J. Lee, Kwang Woo Ahn et al. · Blood · 2014 · 280 citations · Full text

Medicine, Hematology, Immunology +12